Login / Signup

Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial.

Byeong Chae KimYoung Chul YounJee Hyang JeongHyun Jeong HanJong Hun KimJae-Hong LeeKee Hyung ParkKyung Won ParkEun-Joo KimMi-Sun OhYongSoo ShimJong-Min LeeYong-Ho ChoiGilsoon ParkSohui KimHyun Young ParkBora YoonSoo Jin YoonSoo Jin ChoKey Chung ParkDuk L NaSun Ah ParkKyung Won Park
Published in: Stroke (2021)
There was no significant difference between the effects of cilostazol and aspirin on WMC progression in patients with cerebral small vessel disease. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01932203.
Keyphrases
  • white matter
  • low dose
  • subarachnoid hemorrhage
  • cardiovascular events
  • antiplatelet therapy
  • cerebral ischemia
  • type diabetes
  • brain injury
  • coronary artery disease
  • blood brain barrier
  • anti inflammatory drugs